Search
Selected Filter
Filter Results
Displaying 1–10 of 394 diseases results
-
May 2, 2024
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.
-
Apr 30, 2024
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Apr 30, 2024
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Apr 30, 2024
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Apr 30, 2024
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Apr 30, 2024
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Apr 19, 2024
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
The company’s innovative Gene Coding™ platform enables seamless insertion of DNA into selective genomic locations.
-
Apr 16, 2024
Eye on the Cure Podcast | Episode 64: Dr. Kapil Bharti
Kapil Bharti, PhD, a senior investigator and director of the Intramural Research Program at the National Eye Institute (NEI), talks with host Ben Shaberman about his clinical trial underway for an innovative cell therapy for geographic atrophy (advanced dry age-related macular degeneration) as well as a clinical trial of the drug metformin for Stargardt disease.
-
Apr 12, 2024
Phase 3 Clinical Trial of NAC Launched for RP Patients
The drug is thought to work independent of the mutated gene causing RP.
-
Apr 11, 2024
ViGeneron Launches Clinical Trial of Gene Therapy for RP Caused by CNGA1 Mutations
The gene therapy is administered using a less-invasive intravitreal injection.